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Background
3´,5´-cGMP is a well-known second messenger in eukar-
yotic cells which is synthesized by particulate and soluble
guanylyl cyclases and is involved in several cardiovascular
and neurological processes [1,2]. It has been recently
reported that also 2´,3´-cGMP (Figure 1) can be found in
high concentrations in rabbit kidney and pancreas [3]. So
far, little is known about the source and biological role of
2´,3´-cGMP as well as its tissue distribution. To address
this question, we have developed sensitive and specific
liquid chromatography-coupled mass spectrometry (LC-
MS/MS) methods for identification and quantitation of
2´,3´- nucleoside monophosphates (2´,3´-cNMPs) simulta-
neously with 3´,5´-cNMPs (cAMP, cCMP, cGMP, cUMP).
We systematically analyzed mouse tissues (brain, thymus,
heart, lung, liver, pancreas, spleen, kidney, bladder, testis,
ovary, uterus) for the presence of 2’,3’- and 3’,5’-cNMPs,
respectively.
Materials and methods
For cNMP extraction, 30-200 mg tissue was transferred to
a 2.0 mL tube containing a garnet matrix and one ¼ inch
ceramic sphere. An organic extraction solvent was added
and tissues were homogenated in a FastPrep-24® system
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Figure 1 Chemical structures of 3’,5’-cGMP and 2’,3’-cGMP
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(MP Biomedicals, Germany). The homogenate was centri-
fuged and the supernatant fluid was evaporated to dryness
at 40°C under a nitrogen stream. The residue pellet was
resuspended in water and analyzed by LC-MS/MS.
Detection and quantitation of 2’,3’- and 3’,5’-cNMPs
was performed on a tandem mass spectrometer (5500
QTRAP®; AB SCIEX, USA). We confirmed our data on a
TripleTOFTM 5600 system (AB SCIEX, USA) which is
characterized by an extremely high mass accuracy.
Results
The chromatogram of a standard cNMP sample demon-
strates that the LC-MS/MS method is suitable for the
detection and quantitation of 2’,3’- and 3’,5’-cNMPs. Due
to their retention times, all 2’,3’-cNMPs could be reliably
discriminated from their 3’,5’-isomers (Figure 2A).
In addition to 3’,5’-cGMP we detected notable amounts
of 2’,3’-cGMP in various mouse tissues. For example, heart
samples showed an up to 5-fold higher concentration of
2’,3’-cGMP compared with the 3’,5’-cNMP (Figure 2B). In
murine pancreas and spleen only 2’,3’-cGMP but no 3’,5’-
cGMP could be detected.
Besides 2’,3’-cGMP, remarkably high levels of 2’,3’-
cCMP and 2’,3’-cUMP were detected in murine heart,
kidney, spleen, liver, pancreas and lung.
Conclusion
2’,3’-cAMP is an mRNA degradation product. Increased
2’,3’-cAMP concentrations may play a role in cell death
and cell proliferation [4].
We have demonstrated that high levels of 2’,3’-cGMP as
well as 2’,3’-cCMP and 2’,3’-cUMP can be detected in var-
ious murine tissues. Our results indicate that these
cNMPs play an important but still unknown role in
(patho)physiological processes.
To our knowledge, this is the first time that mammalian
tissues were systematically analyzed for the occurrence of
2’,3’-cNMPs. Our methods allow reliable detection and
quantitation of four 2’,3’-cNMPs simultaneously with their
3’,5’-isomers and are, therefore, useful for the characteriza-
tion of the physiological role of 2’,3’-cNMPs.
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Figure 2 A: Representative chromatogram of a 3’,5’- /2’,3’ cNMP standard (I: 2’,3’-cCMP, II: 2’,3’-cUMP, III: 3’,5’-cCMP, IV: 2’,3’-cGMP, V: 3’,5’-cUMP, VI: 3’,5’-
cGMP, VII: 2’,3’-cAMP, VIII: 3’5’-cAMP) B: Detection of 2’,3’-cGMP and 3’,5’-cGMP in murine heart.
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